Lexeo Therapeutics, Inc.'s total assets for Q1 2025 were $125.69M, a decrease of -14.46% from the previous quarter. LXEO total liabilities were $37.58M for the fiscal quarter, a 24.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.